Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02774421
Title Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

malignant ependymoma

Therapies

Sargramostim + Trastuzumab

Age Groups: adult child


No variant requirements are available.